Maximum Dosing of Gabapentin
The maximum recommended dose of gabapentin is 3600 mg per day for both neuropathic pain and epilepsy, with dosing typically divided into three times daily administration. 1
Dosing Guidelines by Indication
For Neuropathic Pain:
- Starting dose: 300 mg on day 1,600 mg on day 2 (300 mg twice daily), 900 mg on day 3 (300 mg three times daily)
- Titration: Increase gradually based on response and tolerability
- Effective dose range: 1800-3600 mg/day
- Maximum dose: 3600 mg/day 2, 1
For Epilepsy:
- Adults and children ≥12 years:
- Starting dose: 300 mg three times daily
- Maintenance dose: 300-600 mg three times daily
- Maximum dose: 3600 mg/day 1
- Children 3-11 years:
- Starting dose: 10-15 mg/kg/day in three divided doses
- Maintenance dose:
- Ages 3-4 years: 40 mg/kg/day in three divided doses
- Ages 5-11 years: 25-35 mg/kg/day in three divided doses
- Maximum dose: Up to 50 mg/kg/day has been well tolerated 1
Dosage Adjustment for Special Populations
Renal Impairment
Dosage reduction is required based on creatinine clearance:
- CrCl ≥60 mL/min: 900-3600 mg/day (300-1200 mg TID)
- CrCl 30-59 mL/min: 400-1400 mg/day (200-700 mg BID)
- CrCl 15-29 mL/min: 200-700 mg/day (100-300 mg QD)
- CrCl <15 mL/min: 100-300 mg/day (100-300 mg QD) 1
Elderly Patients
- Lower starting doses and slower titration are recommended
- Dose should be adjusted based on renal function, which commonly declines with age 1
Administration Guidelines
- Gabapentin can be taken with or without food
- The maximum time between doses should not exceed 12 hours
- If using scored tablets (600 mg or 800 mg), unused half-tablets should be used for the next dose or discarded after 28 days 1
Efficacy Considerations
- For neuropathic pain, clinical trials have demonstrated efficacy across doses from 1800-3600 mg/day
- No additional benefit was consistently demonstrated for doses above 1800 mg/day in postherpetic neuralgia, though some patients may require higher doses 1, 3
- For epilepsy, doses up to 2400 mg/day have been well-tolerated in long-term studies, with doses up to 3600 mg/day administered for shorter durations 1
Common Side Effects
Important Clinical Considerations
- When discontinuing gabapentin, taper gradually over at least 1 week to minimize withdrawal symptoms 1
- Response rates vary by condition: approximately 38% of patients with diabetic neuropathy and 32% with postherpetic neuralgia achieve at least 50% pain reduction 3
- Adverse events are dose-dependent but not necessarily more frequent at higher maintenance doses when appropriate titration is used 4
Gabapentin's unique pharmacokinetics (non-linear absorption due to saturable transport) make careful titration particularly important for optimizing efficacy while minimizing side effects.